0001280776-17-000072.txt : 20170614
0001280776-17-000072.hdr.sgml : 20170614
20170614171323
ACCESSION NUMBER: 0001280776-17-000072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170613
FILED AS OF DATE: 20170614
DATE AS OF CHANGE: 20170614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VITAL THERAPIES INC
CENTRAL INDEX KEY: 0001280776
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15010 AVENUE OF SCIENCE
STREET 2: STE. 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92128
BUSINESS PHONE: 858-673-6840
MAIL ADDRESS:
STREET 1: 15010 AVENUE OF SCIENCE
STREET 2: STE. 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Satter Muneer A
CENTRAL INDEX KEY: 0001315797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36201
FILM NUMBER: 17911835
MAIL ADDRESS:
STREET 1: C/O SATTER INVESTMENT MANAGEMENT, LLC
STREET 2: 676 NORTH MICHIGAN AVENUE, SUITE 4000
CITY: CHICAGO
STATE: IL
ZIP: 60611
4
1
wf-form4_149747478861937.xml
FORM 4
X0306
4
2017-06-13
0
0001280776
VITAL THERAPIES INC
VTL
0001315797
Satter Muneer A
C/O VITAL THERAPIES, INC.
15010 AVENUE OF SCIENCE, SUITE 200
SAN DIEGO
CA
92128
1
0
1
0
Common Stock
2017-06-13
4
P
0
10000
3.0311
A
10942277
I
See Footnotes
Common Stock
2017-06-14
4
P
0
10000
3.1008
A
10952277
I
See Footnotes
All shares were purchased by Satter Medical Technology Partners, L.P.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.95 to $3.10. The reporting person undertakes to provide Vital Therapies, Inc., any security holder of Vital Therapies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price range set forth in this footnote (2) to this Form 4.
The amount in Column 5 includes (a) 4,202,930 shares that are held by the Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares, (b) 2,929,347 shares that are held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares, and (c) the remaining balance of shares are held by Satter Medical Technology Partners, L.P. for which the Reporting Person has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of all shares included in clauses (b) and (c) of this footnote (3), except to the extent of his pecuniary interest.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.025 to $3.25. The reporting person undertakes to provide Vital Therapies, Inc., any security holder of Vital Therapies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price range set forth in this footnote (4) to this Form 4.
/s/ Robert M. Hayward, P.C., by power of attorney
2017-06-14